Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market dynamics of emphysema are complex and influenced by a number of factors including new developments in medical research, increased knowledge about respiratory illnesses and the world healthcare response to chronic obstructive pulmonary diseases (COPD). Emphysema, the most prevalent form of COPD that involves damage to air sacs within the lungs, has attracted much attention among health care providers leading to shaping diagnostic as well as therapeutic approaches. The global incidence of COPD is rising, often associated with prolonged smoking and environmental exposures consequently creating a need for accurate diagnosis tools and effective therapies specific to emphysema.
One major determinant behind the emphysema market is heightened awareness about respiratory health and lifestyle-based lung function consequences. As knowledge on COPD including emphysema grows so does the emphasis placed on prevention measures and early diagnosis. Consequently, this has resulted in development and uptake of more advanced diagnostic techniques such as pulmonary function tests, chest x-rays and CT scans. Early detection is crucial to initiate timely interventions such as lifestyle changes or pharmacotherapy targeting symptom improvement and enhancing life quality among those with emphysema.
Technological advancement plays a key role in increasing market dynamics concerning diagnosis as well as treatment of emphysema. More advanced imaging modalities help to broaden understanding regarding lung injury, disease progression or response to therapy. Inventions in respiratory therapies, inhalation devices plus home monitoring systems empower patients towards self-care. These milestones not only enhance accurate diagnostics but also provide useful tools used in effectively managing emphysema by health professionals including patients.
Emphatically, this has led to incremental efforts by stakeholders especially researchers who are now focusing their studies on how best they can alleviate these cases through coping mechanisms for affected individuals while at the same time providing possible interventions that would reduce cases of morbidity through curative methods. Therefore, bronchodilators along with other modern targeted therapies have been introduced as the key line of treatment in emphysema, aiming to relieve symptoms, slow down progression and enhance prognosis generally. These new therapeutic options have been a critical boost to the market dynamics associated with emphysema treatment.
The competitive landscape of the emphysema market is formed by pharmaceutical companies specializing on respiratory health, manufacturers of medical devices and research institutions contributing towards development of innovative treatments. Highly dynamic markets are characterized by clinical trials and ongoing research initiatives aimed at coming up with novel therapeutic approaches. Thus, stakeholders should collaborate towards advancing emphysema research, promoting innovation and ensuring availability of effective therapies.
Key issues in the dynamics include chronic progressive nature that requires long term management strategies for emphysema. Moreover, environmental risk factors need to be addressed as well as patient compliance with therapy regime alongside personalization of therapeutics especially for health care givers as well as pharmaceutical companies. Inadequacy in these areas necessitate an inclusive approach centered on patients through education involving modification of lifestyle together with continued encouragement.
Emphysema Market Highlights:
Market Synopsis
The global emphysema market is expected to grow UDS 19.7 Billion at a CAGR of 4.20% during the forecast period 2023 to 2030.
Emphysema, a lung disease is characterized by the shortness of breath, thereby, damaging the air sacs in the lungs. The disease leads to rupture and weakening of inner walls of the air sacs over the period. The disease involves the reduction in the surface area of the lungs which in turn reduces the amount of oxygen reaching the bloodstream. Hence, during exhalation, the alveoli do not function properly leaving the air trapped in the lungs, leaving no space for oxygen-rich air to enter the lungs. Emphysema and chronic bronchitis are together known as the Chronic Obstructive Pulmonary Disease (COPD). The patients suffering from emphysema also have chronic bronchitis. The major causes of emphysema are exposure to air pollutants, chemical fumes, and dust and smoking. The condition can be diagnosed through various tests such as imaging tests that include chest X-ray and CT scan and the lung function test.
The global emphysema market is mainly driven by the high prevalence of respiratory diseases such as chronic bronchitis, emphysema, and others and a huge demand for treatment including smoking cessation drugs and antibiotics. Additionally, the rising availability of diagnostic services for respiratory illness also fuels the growth of the market.
According to the World Health Organization, COPD affects nearly 210 million people which is attributed to the increasing population in urban areas across the globe and growing number of tobacco smokers.
FIGURE 1: Global Emphysema Market, by Region, 2016 (%)
 
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, and Company Presentation
Segments Â
The global emphysema market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into centrilobular and panlobular emphysema.
On the basis of diagnosis, the market is segmented into imaging test, lung function test, and others. The imaging test is further segmented into chest X-ray and CT scan.
On the basis of treatment, the market is segmented into medications, therapy, and surgery. Medications are further segmented into smoking cessation drugs, bronchodilators, inhaled steroids, antibiotics, and leukotriene modifiers. Therapy is further segmented into pulmonary rehabilitation, nutrition therapy, gene therapy, and supplemental oxygen. Surgery is further segmented into lung volume reduction surgery, lung transplant, and bullectomy.
On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.
Intended Audience
- Drug Manufacturers
- Drug Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Research Methodology
 
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, and Company Presentation
Regional Analysis of the Global Emphysema Market   Â
The American emphysema market is segmented into two regions, namely, North America and South America. North America, being the largest market, is mainly driven by the increasing use of imaging test and lung function test for the diagnosis of the disease and huge population base diagnosed with COPD. Furthermore, the U.S. is the largest market in North America owing to the presence of large number of market players manufacturing medications for emphysema and increasing awareness about risk factors and cases of the disease. The American Lung Association stated that in the U.S., COPD is the fourth leading cause of deaths. Canada is expected to be the fastest growing market which is driven by the overall increasing demand for diagnostic medical devices with progress in the medical device sector. South America is expected to be the fastest growing market due to technologically advanced devices for diagnosis and the increasing demand for treatment options of respiratory diseases
The European emphysema market exhibits a positive growth with an increasing emphasis on the diagnosis of chronic respiratory conditions such as the COPD and asthma and increasing focus on research and development activities for the treatment of respiratory diseases. Germany and the U.K. are the major contributors to the growth of the market. Additionally, increasing expenditure in healthcare by major countries in Europe also accelerates the growth of the market.
Asia Pacific is expected to be the fastest growing market whose growth is attributed to a huge demand for lung function test and other diagnostic tests and the increasing focus on early diagnosis and treatment of lung diseases. Furthermore, other factors contributing to the growth of the market are lifestyle changes, the influence of western culture among the adults, and addiction to smoking. Additionally, rising environmental pollution and exposure to harmful chemicals also attribute to the growth of the market.
The Middle Eastern and African market for emphysema exhibits a steady rise with an increase in the number of healthcare facilities providing treatment for the chronic condition and the flourishing growth of medical device sector especially the diagnostic devices such as MRI and CT. In the African region, the awareness about COPD is increasing and is fueling the growth of the market.
Key Players in the Global Emphysema Market
Some of the key players in this market are Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc. and others.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
